AM 580

Drug Profile

AM 580

Alternative Names: AGN-190293; AM-580

Latest Information Update: 17 Nov 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator W.R. Grace
  • Developer Mitsubishi Pharma Corporation; Sumitomo Pharmaceuticals
  • Class Antineoplastics; Benzoic acids; Retinoids; Small molecules
  • Mechanism of Action Immunostimulants; Protein synthesis inhibitors; Retinoic acid receptor alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Rheumatoid arthritis

Most Recent Events

  • 06 Apr 2000 Yoshitomi is now called Welfide Corporation
  • 27 Sep 1999 A preclinical study has been added to the drug interactions section
  • 17 Apr 1997 A preclinical study has been added to the Cancer pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top